|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
WO1996032468A2
(en)
|
1995-04-11 |
1996-10-17 |
Merck & Co., Inc. |
Bioprocess for production of dipeptide based compounds
|
|
AU726374B2
(en)
|
1997-03-05 |
2000-11-02 |
University Of Washington |
Novel screening methods to identify agents that selectively inhibit hepatitis C virus replication
|
|
CA2295474A1
(en)
|
1997-07-08 |
1999-01-21 |
Human Genome Sciences, Inc. |
123 human secreted proteins
|
|
AU751784B2
(en)
|
1997-08-29 |
2002-08-29 |
Innogenetics N.V. |
Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
|
|
US6413783B1
(en)
|
1997-09-18 |
2002-07-02 |
Meso Scale Technologies, Llc |
Assay sonication apparatus and methodology
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
JP2004520803A
(ja)
|
2000-04-21 |
2004-07-15 |
コリクサ コーポレイション |
尋常性挫瘡の治療および診断のための組成物および方法
|
|
JP2004518437A
(ja)
|
2000-10-25 |
2004-06-24 |
ディアデクサス インコーポレーテッド |
肺特異的遺伝子およびタンパク質に関する組成物および方法
|
|
AU2002219988A1
(en)
|
2000-11-20 |
2002-05-27 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
US7528227B2
(en)
|
2004-03-23 |
2009-05-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Histone H2A peptide derivatives and uses thereof
|
|
US7163943B2
(en)
|
2001-09-21 |
2007-01-16 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
US7393642B2
(en)
|
2003-07-17 |
2008-07-01 |
Chicago Community Foundation |
Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome
|
|
HUE054805T2
(hu)
|
2003-09-30 |
2021-09-28 |
Univ Pennsylvania |
Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
|
|
WO2005089164A2
(en)
|
2003-12-31 |
2005-09-29 |
Pharmexa Inc. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
WO2005099741A1
(ja)
|
2004-04-08 |
2005-10-27 |
Noevir Co., Ltd. |
運動ニューロン疾患治療薬
|
|
US20060068434A1
(en)
*
|
2004-09-21 |
2006-03-30 |
Jay Stoerker |
Methods and compositions for detecting cancer using components of the U2 spliceosomal particle
|
|
WO2006083800A2
(en)
|
2005-01-31 |
2006-08-10 |
University Of Iowa Research Foundation |
Nucleic acid silencing of huntington's disease gene
|
|
US20090074721A1
(en)
|
2005-06-06 |
2009-03-19 |
Vgx Pharmaceuticals, Inc. |
Methods for treating viral infection with oral or injectibel drug solution
|
|
WO2007058902A1
(en)
|
2005-11-11 |
2007-05-24 |
Aurogen Inc. |
Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
|
|
EP2082225B1
(en)
*
|
2006-09-20 |
2014-01-01 |
The Queen's University of Belfast |
Method to determine whether a tumour cell has invasive and/or metastatic potential and modulating agents of malignant transformation
|
|
US20080188457A1
(en)
|
2007-02-02 |
2008-08-07 |
Braincells, Inc. |
Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
|
|
US20090148866A1
(en)
*
|
2007-05-18 |
2009-06-11 |
Abbott Laboratories |
Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase
|
|
WO2008151833A2
(en)
|
2007-06-13 |
2008-12-18 |
Hochschule Mannheim |
Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
|
|
US20090143418A1
(en)
|
2007-11-30 |
2009-06-04 |
The Regents Of The University Of Michigan |
Compositions and Methods for Preventing and Treating Hair Growth Cycle-Related Conditions
|
|
GB0809821D0
(en)
|
2008-05-30 |
2008-07-09 |
Univ Aberdeen |
Treatment and diagnosis of behavioural disorders
|
|
TW201034684A
(en)
|
2009-02-18 |
2010-10-01 |
Genentech Inc |
Method for inhibiting neurodegeneration
|
|
WO2010115033A2
(en)
|
2009-04-02 |
2010-10-07 |
Regents Of The University Of Minnesota |
Nucleotide repeat expansion-associated polypeptides and uses thereof
|
|
EP2419144B1
(en)
|
2009-04-17 |
2019-08-07 |
Oxford University Innovation Limited |
Composition for delivery of genetic material
|
|
US8993633B2
(en)
|
2009-05-18 |
2015-03-31 |
Fate Therapeutics, (Canada) Inc. |
Treatment of muscle disease characterized by insulin resistance
|
|
US20120220534A1
(en)
|
2009-09-03 |
2012-08-30 |
University Of Tennessee Research Foundation |
Biomarker for neurodegeneration in neurological disease
|
|
KR101133243B1
(ko)
|
2009-10-29 |
2012-04-06 |
국립암센터 |
암의 진단 및 치료를 위한 ｅＩＦ３ｍ의 용도
|
|
US20130085169A1
(en)
|
2010-04-02 |
2013-04-04 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
|
|
TWI654204B
(zh)
*
|
2010-11-30 |
2019-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
具有鈣依存性的抗原結合能力之抗體
|
|
PL3892295T3
(pl)
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
CA2846307C
(en)
|
2011-08-31 |
2020-03-10 |
University College Cardiff Consultants Limited |
Method for diagnosing a neurodegenerative disease
|
|
EA032003B1
(ru)
|
2011-10-28 |
2019-03-29 |
Байоджен Айдек Интернэшнл Нейросайенз Гмбх |
Анти-tdp-43 антитело
|
|
NZ629427A
(en)
|
2012-02-29 |
2016-04-29 |
Sangamo Biosciences Inc |
Methods and compositions for treating huntington’s disease
|
|
KR101417272B1
(ko)
|
2012-05-15 |
2014-07-14 |
경상대학교산학협력단 |
메트포민 및/또는 타이모퀴논을 포함하는 임신중 알코올 노출에 의한 신경질환 치료 또는 예방용 약학적 조성물
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
RS59283B1
(sr)
|
2013-01-22 |
2019-10-31 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Proteini sa dipeptidnim ponovkom kao terapeutsko ciljno mesto kod neurodegenerativnih bolesti sa ekspanzijom heksanukleotidnog ponovka
|
|
WO2014114303A1
(en)
|
2013-01-22 |
2014-07-31 |
Deutsches Zentrum Für Neurodegenerative Erkrankungen |
Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
|
|
US9448232B2
(en)
|
2013-01-24 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Methods and materials for detecting C9ORF72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or C9ORF72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
|
|
CA2904960A1
(en)
|
2013-03-14 |
2014-10-02 |
University Of Florida Research Foundation, Inc. |
Di-amino acid repeat-containing proteins associated with als
|
|
JP6806562B2
(ja)
|
2013-03-15 |
2021-01-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ｅＩＦ２α経路の調節因子
|
|
US10006049B2
(en)
|
2013-05-16 |
2018-06-26 |
University Of Florida Research Foundation, Incorporated |
Hairpin mRNA elements and methods for the regulation of protein translation
|
|
EP2837390A1
(en)
|
2013-08-15 |
2015-02-18 |
Universitäts-Kinderspital beider Basel |
Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders
|
|
WO2016025692A1
(en)
|
2014-08-13 |
2016-02-18 |
The Scripps Research Institute |
Treatment of c9ftd/als by targeting rna expanded repeat sequences
|
|
JP6508996B2
(ja)
*
|
2015-03-24 |
2019-05-08 |
東ソー株式会社 |
β−ＡＮＰによる心不全の検出方法
|
|
WO2016168143A1
(en)
|
2015-04-14 |
2016-10-20 |
Bristol-Myers Squibb Company |
IMMUNOASSAY FOR SOLUBLE PROGRAMMED DEATH-1 (sPD-1) PROTEIN
|
|
WO2016191241A1
(en)
|
2015-05-27 |
2016-12-01 |
Mmc & Company Llc |
Dual target mitochondrial impinging pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
|
|
US10509045B2
(en)
|
2015-05-29 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Methods for diagnosing Huntington's disease
|
|
JP6858181B2
(ja)
*
|
2015-10-02 |
2021-04-14 |
ユリウス−マクシミリアン−ウニヴェルシテート・ヴュルツブルク |
免疫チェックポイントブロッカーを用いる治療の臨床アウトカムを予測するための診断マーカーとしてのｇｄｆ−１５
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
CN109715144A
(zh)
|
2016-08-18 |
2019-05-03 |
奥维德医疗公司 |
使用双胍类治疗发育障碍的方法
|
|
CA3060250A1
(en)
|
2017-04-17 |
2018-10-25 |
University Of Florida Research Foundation, Incorporated |
Regulation of ran protein translation by pkr and eif2a-p pathways
|
|
US12504380B2
(en)
|
2017-09-25 |
2025-12-23 |
University Of Florida Research Foundation, Incorporated |
Immunoassays for detection of ran proteins
|
|
JP7350337B2
(ja)
|
2017-09-26 |
2023-09-26 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． |
神経障害の処置においてｒａｎタンパク質レベルを低下させるためのメトホルミンおよびそのアナログの使用
|
|
JP2021503610A
(ja)
|
2017-11-16 |
2021-02-12 |
ブレインボックス ソルーションズ、インコーポレイテッドＢｒａｉｎｂｏｘ Ｓｏｌｕｔｉｏｎｓ， Ｉｎｃ． |
神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法
|
|
EP3962518A1
(en)
|
2019-05-02 |
2022-03-09 |
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) |
Immunogen for preventing or treating familial frontotemporal dementia (ftd) and/or amyotrophic lateral sclerosis (als)
|
|
EP3994159A4
(en)
|
2019-07-05 |
2023-08-09 |
University of Florida Research Foundation, Incorporated |
METHODS OF TREATING NEUROLOGICAL DISEASES ASSOCIATED WITH THE RAN PROTEIN
|
|
WO2021055880A1
(en)
|
2019-09-20 |
2021-03-25 |
University Of Florida Researchfoundation, Incorporated |
Detection of antibodies against ran proteins from serum and tissue lysates
|
|
EP4034550A4
(en)
|
2019-09-23 |
2023-09-27 |
University of Florida Research Foundation, Incorporated |
VACCINE THERAPY FOR RAN PROTEIN DISEASES
|
|
CA3157503A1
(en)
|
2019-10-10 |
2021-04-15 |
University Of Florida Research Foundation, Incorporated |
Ran proteins as biomarkers in cag/ctg expansion disorders
|
|
WO2021231887A1
(en)
|
2020-05-15 |
2021-11-18 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods of detection of pre-symptomatic als
|
|
EP4440560A1
(en)
|
2021-12-01 |
2024-10-09 |
University Of Florida Research Foundation, Incorporated |
Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies
|
|
US20250164489A1
(en)
|
2022-02-28 |
2025-05-22 |
University Of Florida Research Foundation, Incorporated |
Ran proteins in sporadic amyotrophic lateral sclerosis
|